Web Analytics

3 Latest Announced Rounds

  • $3,200,000
    Seed

    2 Investors

    Hospital & Health Care
    Apr 1st, 2025
  • $35,000,000
    Series A

    3 Investors

    Hospital & Health Care
    Apr 1st, 2025
  • $15,000,000
    Unknown

    2 Investors

    Software Development
    Apr 1st, 2025
$1,996.03M Raised in 59 Funding Rounds in the past 7 Days - View All

Funding Round Profile

LTZ Therapeutics

start up
United States - Redwood City, California
  • 01/06/2023
  • Pre Series A
  • $10,000,000

LTZ Therapeutics is an immunotherapy-focused biotech company pursing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. With main operations in Redwood City, California and Shenzhen, China as well as a team in Heidelberg, Germany, LTZ is dedicated to developing immunotherapies capable of overcoming resistance and boosting anti-tumor immunity based on reverse translational science and emerging biology of tumor microenvironment.


Related People

Robert LiCo Founder

Robert Li United States - Palo Alto, California

N/A